Natural history of dysplasia of the uterine cervix - PubMed (original) (raw)
. 1999 Feb 3;91(3):252-8.
doi: 10.1093/jnci/91.3.252.
Affiliations
- PMID: 10037103
- DOI: 10.1093/jnci/91.3.252
Natural history of dysplasia of the uterine cervix
P Holowaty et al. J Natl Cancer Inst. 1999.
Abstract
Background: A historical cohort of Toronto (Ontario, Canada) women whose Pap smear histories were recorded at a major cytopathology laboratory provided the opportunity to study progression and regression of cervical dysplasia in an era (1962-1980) during which cervical squamous lesions were managed conservatively.
Methods: Actuarial and Cox's survival analyses were used to estimate the rates and relative risks of progression and regression of mild (cervical intraepithelial neoplasia 1 [CIN1]) and moderate (CIN2) dysplasias. In addition, more than 17,000 women with a history of Pap smears between 1970 and 1980 inclusive and who were diagnosed as having mild, moderate, or severe dysplasia were linked to the Ontario Cancer Registry for the outcome of any subsequent cervical cancers occurring through 1989.
Results: Both mild and moderate dysplasias were more likely to regress than to progress. The risk of progression from mild to severe dysplasia or worse was only 1% per year, but the risk of progression from moderate dysplasia was 16% within 2 years and 25% within 5 years. Most of the excess risk of cervical cancer for severe and moderate dysplasias occurred within 2 years of the initial dysplastic smear. After 2 years, in comparison with mild dysplasia, the relative risks for progression from severe or moderate dysplasia to cervical cancer in situ or worse was 4.2 (95% confidence interval [CI] = 3.0-5.7) and 2.5 (95% CI = 2.2-3.0), respectively.
Conclusion: The risk of progression for moderate dysplasia was intermediate between the risks for mild and severe dysplasia; thus, the moderate category may represent a clinically useful distinction. The majority of untreated mild dysplasias were recorded as regressing to yield a normal smear within 2 years.
Comment in
- Old and new issues in cervical cancer control.
Critchlow CW, Kiviat NB. Critchlow CW, et al. J Natl Cancer Inst. 1999 Feb 3;91(3):200-1. doi: 10.1093/jnci/91.3.200. J Natl Cancer Inst. 1999. PMID: 10037093 No abstract available. - Re: Natural history of dysplasia of the uterine cervix.
Nyirjesy I. Nyirjesy I. J Natl Cancer Inst. 1999 Aug 18;91(16):1420-1. doi: 10.1093/jnci/91.16.1420. J Natl Cancer Inst. 1999. PMID: 10451449 No abstract available.
Similar articles
- Dysplasia and the natural history of cervical cancer: early results of the Toronto Cohort Study.
Narod SA, Thompson DW, Jain M, Wall C, Green LM, Miller AB. Narod SA, et al. Eur J Cancer. 1991;27(11):1411-6. doi: 10.1016/0277-5379(91)90022-6. Eur J Cancer. 1991. PMID: 1835857 - Four and a half year follow up of women with dyskaryotic cervical smears.
Fletcher A, Metaxas N, Grubb C, Chamberlain J. Fletcher A, et al. BMJ. 1990 Sep 29;301(6753):641-4. doi: 10.1136/bmj.301.6753.641. BMJ. 1990. PMID: 2224218 Free PMC article. - Is the HSIL subclassification cytologically real and clinically justified?
Milicić-Juhas V, Pajtler M. Milicić-Juhas V, et al. Coll Antropol. 2010 Jun;34(2):395-400. Coll Antropol. 2010. PMID: 20698108 - Dysplasia and early neoplasia of the uterine cervix. A review.
Briggs RM. Briggs RM. Obstet Gynecol Surv. 1979 Jan;34(1):70-99. Obstet Gynecol Surv. 1979. PMID: 375145 Review. No abstract available. - Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.
Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas J, Hernándes, Glazer-Livson S, Jakobsson M, Joronen K, Kiviharju M, Louvanto K, Oksjoki S, Tähtinen R, Virtanen S, Nieminen P, Kyrgiou M, Kalliala I. Tainio K, et al. BMJ. 2018 Feb 27;360:k499. doi: 10.1136/bmj.k499. BMJ. 2018. PMID: 29487049 Free PMC article. Review.
Cited by
- HPV infection status among women of all ages in Jinshan District, Shanghai.
Shanshan C, Jing C, Tao X. Shanshan C, et al. J Int Med Res. 2024 Nov;52(11):3000605241291754. doi: 10.1177/03000605241291754. J Int Med Res. 2024. PMID: 39520119 Free PMC article. - Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study.
Kabanda R, Kiconco A, Ronald A, Beyer KMM, John SA. Kabanda R, et al. BMC Womens Health. 2024 May 18;24(1):296. doi: 10.1186/s12905-024-03129-5. BMC Womens Health. 2024. PMID: 38762723 Free PMC article. - A comprehensive review of m6A research in cervical cancer.
Hu J, Wang S, Li X. Hu J, et al. Epigenomics. 2024;16(10):753-773. doi: 10.2217/epi-2024-0002. Epub 2024 Apr 19. Epigenomics. 2024. PMID: 38639713 Review. - Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
Fernández Villalobos NV, Ruffieux Y, Haas AD, Chinogurei C, Cornell M, Taghavi K, Egger M, Folb N, Maartens G, Rohner E. Fernández Villalobos NV, et al. Int J Cancer. 2024 Jan 15;154(2):273-283. doi: 10.1002/ijc.34707. Epub 2023 Sep 2. Int J Cancer. 2024. PMID: 37658695 - Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women.
Rahman MA, Hasan MM, Hossain A, Alam KM, Sultana R, Mazid MA, Rahman MM. Rahman MA, et al. Asian Pac J Cancer Prev. 2023 Jul 1;24(7):2361-2368. doi: 10.31557/APJCP.2023.24.7.2361. Asian Pac J Cancer Prev. 2023. PMID: 37505767 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials